BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 12437495)

  • 1. Current oral treatments for erectile dysfunction.
    Kalsi JS; Cellek S; Muneer A; Kell PD; Ralph DJ; Minhas S
    Expert Opin Pharmacother; 2002 Nov; 3(11):1613-29. PubMed ID: 12437495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Rho-kinase inhibitor, soluble guanylate cyclase activator and nitric oxide-releasing PDE5 inhibitor: novel approaches to erectile dysfunction.
    Cellek S; Rees RW; Kalsi J
    Expert Opin Investig Drugs; 2002 Nov; 11(11):1563-73. PubMed ID: 12437503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Commentary on apomorphine versus sildenafil for erectile dysfunction.
    Carson CC
    J Urol; 2008 May; 179(5 Suppl):S95-6. PubMed ID: 18405768
    [No Abstract]   [Full Text] [Related]  

  • 4. Mechanisms of action of PDE5 inhibition in erectile dysfunction.
    Corbin JD
    Int J Impot Res; 2004 Jun; 16 Suppl 1():S4-7. PubMed ID: 15224127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Future options for combination therapy in the management of erectile dysfunction in older men.
    Sommer F; Engelmann U
    Drugs Aging; 2004; 21(9):555-64. PubMed ID: 15260511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Therapy of erectile dysfunction in 2005].
    Porst H
    Urologe A; 2003 Oct; 42(10):1330-6. PubMed ID: 14569381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacotherapy for erectile dysfunction.
    Bivalacqua TJ; Champion HC; Hellstrom WJ; Kadowitz PJ
    Trends Pharmacol Sci; 2000 Dec; 21(12):484-9. PubMed ID: 11121838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of nitric oxide in erectile dysfunction: implications for medical therapy.
    Burnett AL
    J Clin Hypertens (Greenwich); 2006 Dec; 8(12 Suppl 4):53-62. PubMed ID: 17170606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pharmacotherapy of erectile dysfunction].
    Shcheplev PA; Nesterov SN; Kukharkin SA; Abdullaev IA; Sidorov DV
    Ter Arkh; 1999; 71(10):76-8. PubMed ID: 10612182
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of erectile dysfunction.
    Dinsmore W
    Int J STD AIDS; 2004 Apr; 15(4):215-21. PubMed ID: 15075013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparative review of the options for treatment of erectile dysfunction: which treatment for which patient?
    Hatzimouratidis K; Hatzichristou DG
    Drugs; 2005; 65(12):1621-50. PubMed ID: 16060698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacotherapeutic advances in the treatment of erectile dysfunction.
    Nehra A; Barrett DM; Moreland RB
    Mayo Clin Proc; 1999 Jul; 74(7):709-21. PubMed ID: 10405703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacology of erectile dysfunction in man.
    Cirino G; Fusco F; Imbimbo C; Mirone V
    Pharmacol Ther; 2006 Aug; 111(2):400-23. PubMed ID: 16443277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SOP conservative (medical and mechanical) treatment of erectile dysfunction.
    Porst H; Burnett A; Brock G; Ghanem H; Giuliano F; Glina S; Hellstrom W; Martin-Morales A; Salonia A; Sharlip I;
    J Sex Med; 2013 Jan; 10(1):130-71. PubMed ID: 23343170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation and diagnostic testing of erectile dysfunction in the era of phosphodiesterase type 5 inhibitors.
    Jacobsohn K; Wang R
    Asian J Androl; 2007 Jan; 9(1):3-7. PubMed ID: 17187154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. This paper continues Professor Adaikan's distinguished involvement in classical pharmacologic research of erectile physiology.
    Pickard R
    Eur Urol; 2007 Jul; 52(1):259-60. PubMed ID: 17616089
    [No Abstract]   [Full Text] [Related]  

  • 17. Erectile dysfunction: expectations beyond phosphodiesterase type 5 inhibition.
    Aversa A; Pili M; Fabbri A; Spera E; Spera G
    J Endocrinol Invest; 2004 Feb; 27(2):192-206. PubMed ID: 15129818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Switching from intracavernous prostaglandin E1 injections to oral sildenafil citrate in patients with erectile dysfunction: results of a multicenter European study. The Sildenafil Multicenter Study Group.
    Giuliano F; Montorsi F; Mirone V; Rossi D; Sweeney M
    J Urol; 2000 Sep; 164(3 Pt 1):708-11. PubMed ID: 10953130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sexual function in hypertensive patients receiving treatment.
    Reffelmann T; Kloner RA
    Vasc Health Risk Manag; 2006; 2(4):447-55. PubMed ID: 17323599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new era in the treatment of erectile dysfunction.
    Padma-Nathan H
    Am J Cardiol; 1999 Sep; 84(5B):18N-23N. PubMed ID: 10503572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.